Dr, Sherri Tenpenny
Course description:
In 2006, a new vaccine was released for teens to eliminate human papilloma viral infections, with a promise preventing cervical cancer in girls. In 2014, the use of the vaccine was expanded for use in boys, to prevent cervical condyloma (venereal warts). This was a lofty promise. In fact, Gardasil appears to be primarily risk with very little – if any – benefit at all. [2 Videos, Length: Vid 1: 36 Min, Vid 2: 41 Min, Downloadable Material, Access to Forums]
What you will learn from this course:
- The number of human papilloma viruses (HPV) in circulation and the number that have been associated with cancer
- The low incidence of HPV infections seen in American women leading to the release of Gardasil targeting this population of women
- The truth about the incidence of cervical cancer in the US
- The real meaning of CIN, cervical intraepithelial neoplasia
- The critically important difference between neoplasia and neoplasm
- The length of time it takes for each CIN classification to progress to the next level, including the extensive time required for CIN 3 lesions to progress to cervical cancer
- The environmental risk factors necessary for the development of cervical cancer
- Why the exposure of the cervical basement membrane is essential before the HPV viruses can bind to the tissue
- The ingredients found in HPV vaccines and the impact of these ingredients on fertility in both boys and women
- The reason why HPV has not been proven to cause cancer, and why Gardasil will remain primarily all risk with no benefit
